Cargando…
Respiratory Review of 2014: Asthma
Asthma is a chronic inflammatory disease of the airway that comprises a variety of etiologies and inflammatory phenotypes. Clinically, there is a wide range of patients with varying severities and responses to individual drugs. The introduction of inhaled corticosteroid therapy has dramatically chan...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286780/ https://www.ncbi.nlm.nih.gov/pubmed/25580139 http://dx.doi.org/10.4046/trd.2014.77.6.237 |
_version_ | 1782351705052020736 |
---|---|
author | Yoon, Ho Il |
author_facet | Yoon, Ho Il |
author_sort | Yoon, Ho Il |
collection | PubMed |
description | Asthma is a chronic inflammatory disease of the airway that comprises a variety of etiologies and inflammatory phenotypes. Clinically, there is a wide range of patients with varying severities and responses to individual drugs. The introduction of inhaled corticosteroid therapy has dramatically changed the treatment of asthma. Recent development of new therapies suggests the possibility of another breakthrough. These can be categorized as follows: anti-cytokine therapies that usually target eosinophilic inflammation, sublingual immunotherapy, and bronchial thermoplasty. In this paper, we will review the major articles related to asthma treatment that were published in 2013. |
format | Online Article Text |
id | pubmed-4286780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | The Korean Academy of Tuberculosis and Respiratory Diseases |
record_format | MEDLINE/PubMed |
spelling | pubmed-42867802015-01-11 Respiratory Review of 2014: Asthma Yoon, Ho Il Tuberc Respir Dis (Seoul) Review Asthma is a chronic inflammatory disease of the airway that comprises a variety of etiologies and inflammatory phenotypes. Clinically, there is a wide range of patients with varying severities and responses to individual drugs. The introduction of inhaled corticosteroid therapy has dramatically changed the treatment of asthma. Recent development of new therapies suggests the possibility of another breakthrough. These can be categorized as follows: anti-cytokine therapies that usually target eosinophilic inflammation, sublingual immunotherapy, and bronchial thermoplasty. In this paper, we will review the major articles related to asthma treatment that were published in 2013. The Korean Academy of Tuberculosis and Respiratory Diseases 2014-12 2014-12-31 /pmc/articles/PMC4286780/ /pubmed/25580139 http://dx.doi.org/10.4046/trd.2014.77.6.237 Text en Copyright©2014. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved. http://creativecommons.org/licenses/by-nc/3.0/ It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) |
spellingShingle | Review Yoon, Ho Il Respiratory Review of 2014: Asthma |
title | Respiratory Review of 2014: Asthma |
title_full | Respiratory Review of 2014: Asthma |
title_fullStr | Respiratory Review of 2014: Asthma |
title_full_unstemmed | Respiratory Review of 2014: Asthma |
title_short | Respiratory Review of 2014: Asthma |
title_sort | respiratory review of 2014: asthma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286780/ https://www.ncbi.nlm.nih.gov/pubmed/25580139 http://dx.doi.org/10.4046/trd.2014.77.6.237 |
work_keys_str_mv | AT yoonhoil respiratoryreviewof2014asthma |